Evidence map›Paper›PMID 30424180›Full record

ReviewMicromachines2018

Fluorescent Nanodiamond Applications for Cellular Process Sensing and Cell Tracking.

Sandra Claveau, Jean-Rémi Bertrand, François Treussart

Open access · goldAbstract readReview
In one paragraph

Review in Micromachines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. In Vivo Nanodiamond Quantum Sensing of Free Radicals in Caenorhabditis elegans Models.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sandra ClaveauVectorology and Anticancer Therapies, UMR 8203, CNRS, Univ. Paris-Sud, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France. sandra.claveau@gustaveroussy.fr.
Jean-Rémi BertrandLaboratoire Aimé Cotton, CNRS, Univ. Paris-Sud, ENS Paris-Saclay, Université Paris-Saclay, 91405 Orsay, France. jean-remi.bertrand@gustaveroussy.fr.
François TreussartVectorology and Anticancer Therapies, UMR 8203, CNRS, Univ. Paris-Sud, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France. francois.treussart@ens-paris-saclay.fr.ORCID 0000-0002-1755-0688
Université Paris-Sud · FR

Funding

Agence Nationale de la Recherche ANR-14-ENM2-0002
6 · The paper itself

Abstract

Diamond nanocrystals smaller than 100 nm (nanodiamonds) are now recognized to be highly biocompatible. They can be made fluorescent with perfect photostability by creating nitrogen-vacancy (NV) color centers in the diamond lattice. The resulting fluorescent nanodiamonds (FND) have been used since the late 2000s as fluorescent probes for short- or long-term analysis. FND can be used both at the subcellular scale and the single cell scale. Their limited sub-diffraction size allows them to track intracellular processes with high spatio-temporal resolution and high contrast from the surrounding environment. FND can also track the fate of therapeutic compounds or whole cells in the organs of an organism. This review presents examples of FND applications (1) for intra and intercellular molecular processes sensing, also introducing the different potential biosensing applications based on the optically detectable electron spin resonance of NV

Indexed as

bioimagingbiosensingnanodiamondnitrogen-vacancy defectssingle particle tracking

Identifiers

PMID30424180
PMCPMC6187705
OpenAlexW2803909517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.